RBV Capital

Investor type Venture Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 9
Average round size
info
The average size of a deal this fund participated in
$19M
Portfolio companies 7
Rounds per year 1.12
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.33
Exits 2
Key employees 3
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Biotechnology
  • Pharmaceutical
  • Therapeutics
  • Artificial Intelligence
  • Health Care
Summary

In 2013 was created RBV Capital, which is appeared as VC. The main department of described VC is located in the Moscow. The fund was located in Europe if to be more exact in Russian Federation.

Among the most popular portfolio startups of the fund, we may highlight Image Analysis, Bonti, RetroSense Therapeutics. The fund has exact preference in some founders of portfolio startups. Among the most successful fund investment fields, there are Genetics, Therapeutics. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States.

This RBV Capital works on 11 percentage points more the average amount of lead investments comparing to the other organizations. The common things for fund are deals in the range of 10 - 50 millions dollars. The real fund results show that this VC is 40 percentage points more often commits exit comparing to other companies. The fund is generally included in less than 2 deals every year. The top amount of exits for fund were in 2018. The high activity for fund was in 2019.

Besides them, we counted 3 critical employees of this fund in our database.

The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the RBV Capital, startups are often financed by Technium Partners, Tim Draper, Tech Coast Angels. The meaningful sponsors for the fund in investment in the same round are Versant Ventures, Sectoral Asset Management, Santen Pharmaceutical. In the next rounds fund is usually obtained by City Hill Ventures.

Read more

Funds with similar focus

Funds from Russia
Funds with similar focus located in Russia:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Aultman Health Foundation -
Beyond Standard Japan, Tokyo
Dachen Chuanglian China, Guangdong, Shenzhen
Dineout India, Noida, Uttar Pradesh
Frontier Angel Fund Montana, Polson, United States
Loudspring Finland, Helsinki, Southern Finland
Partners Group Baar, Switzerland, Zug
Plug and Play FinTech California, Sunnyvale, United States
TUI Group Germany, Hanover, Niedersachsen
Xiamen University Asset Management Company Limited China, Fujian, Xiamen

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Pipeline Therapeutics

Pharmaceutical
$80M11 Feb 2021 San Diego, California, United States

Pandica

Health Care
Medical Device
$1M25 Dec 2020 Saint Petersburg, Saint Petersburg, Russia

Botkin.AI

Artificial Intelligence
Health Care
Software
$2M23 Dec 2020 Moscow, Moscow, Russia

Pipeline Therapeutics

Pharmaceutical
$32M18 Dec 2019 San Diego, California, United States

Botkin.AI

Artificial Intelligence
Health Care
Software
$1M28 May 2019 Moscow, Moscow, Russia

Immusoft

Biotechnology
Life Science
Therapeutics
$20M03 Jan 2019 Seattle, Washington, United States

RetroSense Therapeutics

Biotechnology
Genetics
Life Science
Therapeutics
$6M12 Nov 2015 Ann Arbor, Michigan, United States

Artificial Intelligence
Biotechnology
Clinical Trials
Cloud Computing
Cloud Infrastructure
Image Recognition
Machine Learning
Medical
Pharmaceutical
Venture Capital
$5M30 Apr 2015 London, England, United Kingdom

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent RBV Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: